- 询价
- Biotium
- 美国
- 41028-25G
- 2025年07月22日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
室温
- 英文名：
Agarose LE, Ultra-Pure Molecular Biology Grade,25G 41028-25G
- 库存：
99
- 供应商：
Biotium
- CAS号：
1
Ultra-Pure LE Agarose can be used for all routine electrophoresis applications. This agarose has excellent performance for analytical or preparative nucleic acid electrophoresis and blotting.
- High quality, molecular biology grade agarose
- Excellent DNA resolution with low background
- No detectable DNase/RNase activity
- Ideal for all routine electrophoresis and blotting applications
It has low electroendosmosis (EEO) which confers high electrophoretic mobility. Ultra-pure LE Agarose has high strength and shows low background after staining with common nucleic acid dyes. Each lot is validated for use with Biotium’s GelRed®, GelGreen®, and DNAzure® gel stains.
High Quality and High Performance
Biotium’s Ultra-Pure LE Agarose has been evaluated to meet the follows specifications; moisture, ash and sulfate content, electroendosmosis, clarity, gel strength, gelling temperature, melting temperature, and DNase/RNase activity. See Sidebar or PI for details.
Also see our GelRed® Agarose, precoated with non-toxic, non-mutagenic GelRed® Dye, for greater safety and convenience.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR product purification-Molecular Biology
product on agarose gel 1% check you DNA band.If your DNA band is too low, pool 2 or 3 PCR and run on agarose gel for purification.Use the minimum agarose% to minimise lost of sample.I'm using Qiagen minielute and it give me great results in a range of 400
Recovering DNA from agarose gels
gives high yields of DNA , but can only be used with the high-grade LMP agarose because it has fewer sulfate groups, which inhibit GELase activity. Unfortunately, this method is time consuming since the digestion takes several hours or overnight
that replicate the diverse genetic and molecular landscape of breast cancer are critical for developing the next?generation therapeutic entities that can target specific cancer subtypes. Patient?derived tumorgrafts, generated by transplanting primary human tumor
